Alhamadani, I., Alzyadi, M. and Majeed, M. (2026) “Prognostic Significance of the CXCL11/CXCL9/CD163 Immune Signature in Triple-Negative Breast Cancer: A Bioinformatics and Survival Analysis: CXCL11/CXCL9 prognostic value”, Archives of Breast Cancer, 13(2), pp. 154–165. doi: 10.32768/abc.6274819305-647.